Eleven cases (44%) were completely negative for HACE1 staining, while the remaining 14 cases showed variable degrees of HACE1 staining, ranging from positive staining in 5–90% of tumor cells, with a median value of 40%. This evidence concerns the gene HACE1 and neoplasm.